ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 274 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $766,758 | +9.8% | 1,783 | +0.5% | 0.00% | 0.0% |
| Q1 2024 | $698,456 | +0.2% | 1,774 | -3.2% | 0.00% | 0.0% |
| Q4 2023 | $696,947 | -18.1% | 1,832 | +5.9% | 0.00% | -25.0% |
| Q3 2023 | $850,522 | +22.0% | 1,730 | -3.3% | 0.00% | +33.3% |
| Q2 2023 | $697,225 | -2.8% | 1,789 | -7.1% | 0.00% | 0.0% |
| Q1 2023 | $717,223 | +6.3% | 1,925 | +8.1% | 0.00% | 0.0% |
| Q4 2022 | $674,700 | +5.3% | 1,781 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $641,000 | -2.4% | 1,816 | +4.8% | 0.00% | 0.0% |
| Q2 2022 | $657,000 | -7.2% | 1,733 | -22.8% | 0.00% | 0.0% |
| Q1 2022 | $708,000 | – | 2,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |